Trial Site Detail

 

Drug:
IPI-504
Trial:
Study of IPI-504 in GIST patients following failure of at least imatinib and sunitinib
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Terminated

 

Universistatsklinikum Mannheim

     
Mannheim , 68167
Germany

 

Principal Investigator:
 Peter Hohnberger, MD
Contact:
 Sonja Kogel +49 (0) 621 383 2042 sonja.koegel@chir.ma.uni-heidelberg.de
Activation Status of this Site:
 Closed
Notes about this Site:
Universistatsklinikum Mannheim Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.